| | |
| Clinical data | |
|---|---|
| Trade names | Atuss, Cothera, Cotrane, Perlatos, Pulmoll, Tussizid |
| AHFS/Drugs.com | International Drug Names |
| ATC code | |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| KEGG | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.006.838 |
| Chemical and physical data | |
| Formula | C19H22N2O3S |
| Molar mass | 358.46 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
Dimethoxanate (trade names Cothera, Cotrane, Atuss, Perlatoss, Tossizid) [1] is a cough suppressant of the phenothiazine class. [2]
Dimethoxanate may have analgesic, local anesthetic, and central nervous system depressant effects, but it may also produce nausea and vomiting. [3]
It binds to the sigma-1 receptor in the brain with an IC50 of 41 nM. [4]
Dimethoxanate was introduced in Austria, Belgium, and France in 1911, and in Italy and Spain in 1963. [5] Approval for marketing in the US was withdrawn by the FDA in 1975 due to lack of evidence of efficacy. [6]
Phenothiazine (1) is reacted with phosgene to give Phenothiazine-10-carbonyl chloride [18956-87-1] (2). Further reaction with 2-(2-(dimethylamino)ethoxy)ethanol [1704-62-7] (3) completed the synthesis of Dimethoxanate (4).